MARINUS PHARMACEUTICALS CEO Scott Braunstein's 2021 pay slips 2% to $4M

MARINUS PHARMACEUTICALS reports 2021 executive compensation

By ExecPay News

Published: April 11, 2022

MARINUS PHARMACEUTICALS reported fiscal year 2021 executive compensation information on April 11, 2022.
In 2021, three executives at MARINUS PHARMACEUTICALS received on average a compensation package of $3M, a 15% increase compared to previous year.
Average pay of disclosed executives at MARINUS PHARMACEUTICALS
Scott Braunstein, Chief Executive Officer, received $4M in total, which decreased by 2% compared to 2020. 78% of Braunstein's compensation, or $3.1M, was in option awards. Braunstein also received $268K in non-equity incentive plan, $574K in salary, as well as $27K in other compensation.
Steven Pfanstiel, Chief Financial Officer, received a compensation package of $3.2M. 83% of the compensation package, or $2.6M, was in option awards.
Joseph Hulihan, Chief Medical Officer, earned $1.9M in 2021, a 55% increase compared to previous year.

Related executives

Scott Braunstein

MARINUS PHARMACEUTICALS

Chief Executive Officer

Steven Pfanstiel

MARINUS PHARMACEUTICALS

Chief Financial Officer

Joseph Hulihan

MARINUS PHARMACEUTICALS

Chief Medical Officer

You may also like

Source: SEC filing on April 11, 2022.